NCT04127825View on ClinicalTrials.gov

Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Surgery--ComplicationsBlood Transfusion Complication
Interventions
PROCEDURE

Acute Normovolemic Hemodilution (ANH)

Acute normovolemic hemodilution (ANH) is a method of blood conservation used to reduce the amount of donor blood transfused. It involves removing blood from appropriate patients immediately after the induction of anesthesia, replacing the volume lost with colloids (e.g. 5% albumin), then storing and returning this blood to the patient at the completion of the surgical procedures.

Trial Locations (1)

55455

University of Minnesota Medical Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04127825 - Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter